Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7531140
Reference Type
Journal Article
Title
Prognostic value of lymphovascular space invasion in endometrial cancer
Author(s)
Puljiz, M; Puljiz, Ž; Danolić, D; Alvir, I; Tomica, D; Mamić, I; Vučemilo, T; Perić Balja, M; Zorica, R
Year
2013
Is Peer Reviewed?
1
Journal
Ljekarska Komora Zenicko-Dobojskog Kantona. Medicinski Glasnik
ISSN:
1840-0132
EISSN:
1840-2445
Volume
10
Issue
2
Page Numbers
288-292
Language
English
PMID
23892846
Abstract
AIM:
To evaluate the prognostic significance of lymphovascular space invasion (LVSI) in endometrial cancer (EC) patients.
METHODS:
A total of 73 patients who underwent surgery for endometrial cancer at the University Hospital for Tumors, Zagreb, Croatia and University Hospital Centre Split, Croatia, in the period from 1999 to 2008 were evaluated.
RESULTS:
Lymphovascular space invasion was identified in 58 cases (79.5%). Univariate analysis and multivariate analysis demonstrated a significant association between LVSI and EC recurrence (p=0.004; HR 0.241, CI 0.114-0.511). The median time from diagnosis to EC recurrence of patients with positive LVSI was 20 months, and the median time from diagnosis to EC recurrence of patients with negative LVSI was 86 months (relative risk of recurrence 0.24).
CONCLUSION:
Lymphovascular space invasion identified on routine haematoxylin and eosin stained sections, is a significant independent predictor of endometrial cancer recurrence.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity